194 related articles for article (PubMed ID: 22177040)
21. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
22. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.
Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS
J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785
[TBL] [Abstract][Full Text] [Related]
23. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
24. Level IIb lymph node metastasis in neck dissection for papillary thyroid carcinoma.
Lee BJ; Wang SG; Lee JC; Son SM; Kim IJ; Kim YK
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1028-30. PubMed ID: 17938327
[TBL] [Abstract][Full Text] [Related]
25. [Central compartment lymph node metastasis in cN0 papillary thyroid carcinoma].
Yan DG; Zhang B; Wang JY; Xu ZG; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Nov; 45(11):891-4. PubMed ID: 21215200
[TBL] [Abstract][Full Text] [Related]
26. Should Level V Be Routinely Dissected in N1b Papillary Thyroid Carcinoma?
Kim SK; Park I; Hur N; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):253-260. PubMed ID: 27762727
[TBL] [Abstract][Full Text] [Related]
27. Level I lymph node involvement in patients with N1b papillary thyroid carcinoma: a prospective study.
Eweida AM; Sakr MF; Hamza Y; Khalil MR; Gabr E; Koraitim T; Al-Wagih HF; Abo-Elwafa W; Ezzat Abdel-Aziz T; Diab AA; El-Sabaa B; Nabawi AS
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1951-1958. PubMed ID: 27999997
[TBL] [Abstract][Full Text] [Related]
28. Patterns of Occult Metastasis to Level Va and Vb in Clinically Lateral Node-Positive Papillary Thyroid Carcinoma.
Song K; Jin Y; Kim M; Moon S; Heo DB; Won HR; Chang JW; Koo BS
Ann Surg Oncol; 2022 Apr; 29(4):2550-2556. PubMed ID: 34792697
[TBL] [Abstract][Full Text] [Related]
29. [Study on the relationship between ultrasonographic features of papillary thyroid carcinoma and central cervical lymph node metastasis].
Wang XQ; Wei W; Wei X; Xu Y; Wang HL; Xing XJ; Zhang S
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):196-200. PubMed ID: 29575838
[No Abstract] [Full Text] [Related]
30. Accuracy of intraoperative determination of central node metastasis by the surgeon in papillary thyroid carcinoma.
Ji YB; Lee DW; Song CM; Kim KR; Park CW; Tae K
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):542-7. PubMed ID: 24429357
[TBL] [Abstract][Full Text] [Related]
31. Dissection of Levels II Through V Is Required for Optimal Outcomes in Patients with Lateral Neck Lymph Node Metastasis from Papillary Thyroid Carcinoma.
Javid M; Graham E; Malinowski J; Quinn CE; Carling T; Udelsman R; Callender GG
J Am Coll Surg; 2016 Jun; 222(6):1066-73. PubMed ID: 27049777
[TBL] [Abstract][Full Text] [Related]
32. Clinical value of dual-energy CT for predicting occult metastasis in central neck lymph nodes of papillary thyroid carcinoma.
Zhao W; Shen S; Ke T; Jiang J; Wang Y; Xie X; Hu X; Tang X; Han D; Chen J
Eur Radiol; 2024 Jan; 34(1):16-25. PubMed ID: 37526667
[TBL] [Abstract][Full Text] [Related]
33. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma.
Lei J; Zhong J; Jiang K; Li Z; Gong R; Zhu J
Oncotarget; 2017 Apr; 8(16):27022-27033. PubMed ID: 28223546
[TBL] [Abstract][Full Text] [Related]
34. Occult Contralateral Lateral Lymph Node Metastases in Unilateral N1b Papillary Thyroid Carcinoma.
Bohec H; Breuskin I; Hadoux J; Schlumberger M; Leboulleux S; Hartl DM
World J Surg; 2019 Mar; 43(3):818-823. PubMed ID: 30465086
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma.
Wei T; Chen R; Zou X; Liu F; Li Z; Zhu J
Eur J Surg Oncol; 2015 Jun; 41(6):746-50. PubMed ID: 25882035
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases.
Yang J; Gong Y; Yan S; Zhu J; Li Z; Gong R
Cancer Med; 2016 Aug; 5(8):2161-8. PubMed ID: 27368106
[TBL] [Abstract][Full Text] [Related]
37. REGγ Is Associated with Lymph Node Metastasis and T-Stage in Papillary Thyroid Carcinoma.
Qi L; He W
Med Sci Monit; 2018 Mar; 24():1373-1378. PubMed ID: 29509725
[TBL] [Abstract][Full Text] [Related]
38. BRAF V600E mutation: Differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma.
Kim SK; Lee JH; Woo JW; Park I; Choe JH; Kim JH; Kim JS
Head Neck; 2016 Apr; 38 Suppl 1():E1203-9. PubMed ID: 26268700
[TBL] [Abstract][Full Text] [Related]
39. Predictive factors of skip metastases to lateral neck compartment leaping central neck compartment in papillary thyroid carcinoma.
Lim YC; Koo BS
Oral Oncol; 2012 Mar; 48(3):262-5. PubMed ID: 22047924
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors for Central Neck Lymph Node Metastases in Micro- Versus Macro- Clinically Node Negative Papillary Thyroid Carcinoma.
Sessa L; Lombardi CP; De Crea C; Tempera SE; Bellantone R; Raffaelli M
World J Surg; 2018 Mar; 42(3):623-629. PubMed ID: 29238850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]